Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2023International Journal of Antimicrobial AgentsOpen Access

Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDavid M. LivermoreSMShazad MushtaqAVAnna Vickers

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Livermore et al. (2023) studied this question.

synapsesocial.com/papers/69ff9789da5c1eb07f2d7f3dhttps://doi.org/10.1016/j.ijantimicag.2023.106776
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing <i>Enterobacteriaceae</i>2010 · 257 citations
  2. 2<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 20152017 · 193 citations
  3. 3Struggle To Survive: the Choir of Target Alteration, Hydrolyzing Enzyme, and Plasmid Expression as a Novel Aztreonam-Avibactam Resistance Mechanism2020 · 33 citations
  4. 4Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007–192021 · 21 citations
  5. 5<i>Escherichia coli</i> strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance study2020 · 62 citations